{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:35:20Z","timestamp":1768390520736,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,13]]},"DOI":"10.7759\/cureus.101495","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:03:26Z","timestamp":1768374206000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Analysis of Procalcitonin and C-Reactive Protein in Bloodstream Infections Among Febrile Neutropenic Pediatric Cancer Patients"],"prefix":"10.7759","author":[{"given":"Tanya","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RajKumar","family":"Kalyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Sachan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushmita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Management and preventive measures for febrile neutropenia","volume":"43","author":"Lucas AJ","year":"2018","unstructured":"Lucas AJ, Olin JL, Coleman MD. Management and preventive measures for febrile neutropenia. P T. 2018, 43:228-32.","journal-title":"P T"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.11.012","article-title":"Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients","volume":"57","author":"Urbonas V","year":"2012","unstructured":"Urbonas V, Eidukait\u0117 A, Tamulien\u0117 I. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients. Cytokine. 2012, 57:313-15. 10.1016\/j.cyto.2011.11.012","journal-title":"Cytokine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27887","article-title":"Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer","volume":"66","author":"Arif T","year":"2019","unstructured":"Arif T, Phillips RS. Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer. Pediatr Blood Cancer. 2019, 66:e27887. 10.1002\/pbc.27887","journal-title":"Pediatr Blood Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24158","article-title":"Biomarkers for risk stratification of febrile neutropenia among children with malignancy: a pilot study","volume":"59","author":"Mian A","year":"2012","unstructured":"Mian A, Becton D, Saylors R, James L, Tang X, Bhutta A, Prodhan P. Biomarkers for risk stratification of febrile neutropenia among children with malignancy: a pilot study. Pediatr Blood Cancer. 2012, 59:238-45. 10.1002\/pbc.24158","journal-title":"Pediatr Blood Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.115624","article-title":"Interleukin-5, interleukin-6, interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia","volume":"31","author":"Aggarwal R","year":"2013","unstructured":"Aggarwal R, Bansal D, Bansal F, Nanda N, Ray P, Trehan A, Marwaha RK. Interleukin-5, interleukin-6, interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia. Indian J Med Microbiol. 2013, 31:226-29. 10.4103\/0255-0857.115624","journal-title":"Indian J Med Microbiol"},{"key":"ref6","article-title":"Clinical utility and measurement of procalcitonin","volume":"38","author":"Samsudin I","year":"2017","unstructured":"Samsudin I, Vasikaran SD. Clinical utility and measurement of procalcitonin. Clin Biochem Rev. 2017, 38:59-68.","journal-title":"Clin Biochem Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.1.396","article-title":"Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis","volume":"86","author":"M\u00fcller B","year":"2001","unstructured":"M\u00fcller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001, 86:396-404. 10.1210\/jc.86.1.396","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab152","article-title":"CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia","volume":"3","author":"Banerjee R","year":"2021","unstructured":"Banerjee R. CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia. JAC Antimicrob Resist. 2021, 3:dlab152. 10.1093\/jacamr\/dlab152","journal-title":"JAC Antimicrob Resist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02458.x","article-title":"Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II","volume":"111","author":"Fleischhack G","year":"2000","unstructured":"Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol. 2000, 111:1093-102. 10.1046\/j.1365-2141.2000.02458.x","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.175360","article-title":"Bloodstream infections in pediatric patients at Cancer Institute, Chennai","volume":"51","author":"Radhakrishnan V","year":"2014","unstructured":"Radhakrishnan V, Vijaykumar V, Ganesan P, Rajendranath R, Trivadi G, Tenali S. Bloodstream infections in pediatric patients at Cancer Institute, Chennai. Indian J Cancer. 2014, 51:418-19. 10.4103\/0019-509X.175360","journal-title":"Indian J Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"Freifeld AG","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, et al.. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011, 52:e56-93. 10.1093\/cid\/cir073","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5455\/msm.2013.25.23-25","article-title":"Serum procalcitonine levels as an early diagnostic indicator of sepsis","volume":"25","author":"Beqja-Lika A","year":"2013","unstructured":"Beqja-Lika A, Bulo-Kasneci A, Refatllari E, Heta-Alliu N, Rucaj-Barbullushi A, Mone I, Mitre A. Serum procalcitonine levels as an early diagnostic indicator of sepsis. Mater Sociomed. 2013, 25:23-5. 10.5455\/msm.2013.25.23-25","journal-title":"Mater Sociomed"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.19.00147","article-title":"Procalcitonin and C-reactive protein as markers of bacteremia in patients with febrile neutropenia who receive chemotherapy for acute leukemia: a prospective study from Nepal","volume":"5","author":"Shilpakar R","year":"2019","unstructured":"Shilpakar R, Paudel BD, Neupane P, et al.. Procalcitonin and C-reactive protein as markers of bacteremia in patients with febrile neutropenia who receive chemotherapy for acute leukemia: a prospective study from Nepal. J Glob Oncol. 2019, 5:1-6. 10.1200\/JGO.19.00147","journal-title":"J Glob Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000063440.19188.ED","article-title":"Comparison of procalcitonin and C-reactive protein as markers of sepsis","volume":"31","author":"Luzzani A","year":"2003","unstructured":"Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003, 31:1737-41. 10.1097\/01.CCM.0000063440.19188.ED","journal-title":"Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-7-137","article-title":"Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults","volume":"7","author":"Massaro KS","year":"2007","unstructured":"Massaro KS, Costa SF, Leone C, Chamone DA. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis. 2007, 7:137. 10.1186\/1471-2334-7-137","journal-title":"BMC Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/cc306","article-title":"Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS","volume":"3","author":"Meisner M","year":"1999","unstructured":"Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 1999, 3:45-50. 10.1186\/cc306","journal-title":"Crit Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3180320b5b","article-title":"Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia","volume":"29","author":"Secmeer G","year":"2007","unstructured":"Secmeer G, Devrim I, Kara A, et al.. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol. 2007, 29:107-11. 10.1097\/MPH.0b013e3180320b5b","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60101560","article-title":"The utility of c-reactive protein, procalcitonin, and leukocyte values in predicting the prognosis of patients with pneumosepsis and septic shock","volume":"60","author":"Doganci M","year":"2024","unstructured":"Doganci M, Eraslan Doganay G, Sazak H, et al.. The utility of c-reactive protein, procalcitonin, and leukocyte values in predicting the prognosis of patients with pneumosepsis and septic shock. Medicina (Kaunas). 2024, 60:10.3390\/medicina60101560","journal-title":"Medicina (Kaunas)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1563170","article-title":"Clinical application of combined CRP and PCT detection in diagnosing and prognosing fracture-related infections","volume":"15","author":"Liu X","year":"2025","unstructured":"Liu X, Lian J, Liu F, Han D, Sang C. Clinical application of combined CRP and PCT detection in diagnosing and prognosing fracture-related infections. Front Cell Infect Microbiol. 2025, 15:1563170. 10.3389\/fcimb.2025.1563170","journal-title":"Front Cell Infect Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13071213","article-title":"Performance comparison of procalcitonin, delta neutrophil index, c-reactive protein, and serum amyloid a levels in patients with hematologic diseases","volume":"13","author":"Cho J","year":"2023","unstructured":"Cho J, Lee JH, Lee DH, Kim J, Uh Y. Performance comparison of procalcitonin, delta neutrophil index, c-reactive protein, and serum amyloid a levels in patients with hematologic diseases. Diagnostics (Basel). 2023, 13:10.3390\/diagnostics13071213","journal-title":"Diagnostics (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440981-comparative-analysis-of-procalcitonin-and-c-reactive-protein-in-bloodstream-infections-among-febrile-neutropenic-pediatric-cancer-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:03:26Z","timestamp":1768374206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440981-comparative-analysis-of-procalcitonin-and-c-reactive-protein-in-bloodstream-infections-among-febrile-neutropenic-pediatric-cancer-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.101495","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}